Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160026/S074

LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

Physio-Control, Inc. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONP160026/S074

What did the FDA decide?

Physio-Control, Inc. holds PMA P160026 for the LIFEPAK 1000 defibrillator, LIFEPAK 20 defibrillator/monitor, LIFEPAK 20E defibrillator/monitor and LIFEPAK 15 monitor/defibrillator, product code MKJ. Supplement S074, a 30-day notice, records a process change attributed to the manufacturer, sterilizer, packager or supplier. The listed purpose is implementation of an automated inspection process, and FDA recorded the decision as OK30 on 2026-09-24.

The record does not identify the component or line affected, the prior inspection method, the validation performed, or any change to device design, labeling or indications. The identifier establishes only that S074 sits within the P160026 PMA, not that the full system was newly approved. The stated purpose of an automated inspection process is the applicant's description of the change; the filing supplies no independent evidence of safety or clinical effectiveness, and none is inferred here.

FDA approval order statement

implementation of an automated inspection process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 24, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160026/S074
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
OK30
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

For the original device and its historical approval scope, see PMA P160026. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160026 · Original PMA

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  2. P160026/S074 received

    Application receipt date recorded by FDA.

  3. P160026/S069 · Related supplement

    LIFEPAK 35 monitor/defibrillator

  4. P160026/S073 · Related supplement

    LIFEPAK 15 monitor/defibrillator

  5. P160026/S074 · FDA decision

    30-Day Notice

  6. P160026/S076 · Related supplement

    LIFEPAK 35 monitor/defibrillator

Timeline entries are records held by MedtechLedger for P160026. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160026

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Physio-Control, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11811 Willows Rd. NE, Redmond, WA, 98052

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records